Cuban Pharmaceutical Products from Havana
Cuba's biotechnology sector has developed a family of innovative products — from neuroprotective agents and cancer vaccines to wound-healing growth factors and dermatological treatments. Each product is developed by Cuba's leading research institutions and is available to international patients through SMC Salud.
Six Pioneering Cuban Products
Each product is a Cuban-developed biotechnology therapy with its own mechanism of action, clinical evidence, and treatment protocol. Click any product to learn more.
Cancer & Oncology
2CIMAvax-EGF
A therapeutic cancer vaccine for advanced non-small cell lung cancer that prompts the immune system to attack the EGF growth signal that tumors need to grow.
Vaxira (Racotumomab)
A therapeutic cancer vaccine targeting NeuGcGM3 ganglioside antigens found on the surface of lung tumor cells — an alternative or complementary approach to CIMAvax-EGF.
Skin & Dermatology
2Melagenin Plus
A Cuban-developed topical medication from human placental extract that stimulates melanocyte activity to help restore skin color in vitiligo.
Coriodermina
A Cuban-developed topical medication from human placental extract that regulates skin cell growth and reduces inflammation in psoriasis.
Ready to Learn More?
Take the next step. Our international patient coordinators are here to help you understand your options.
Treatment suitability depends on specialist evaluation. Individual treatment plans apply.